- Home
- ERAS vs DEA Comparison
ERAS vs DEA Comparison
Compare ERAS & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERAS | DEA |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ERAS | DEA |
|---|---|---|
| Price | $13.56 | $22.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $11.38 | ★ $24.99 |
| AVG Volume (30 Days) | ★ 3.7M | 458.2K |
| Earning Date | 03-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 8.14% |
| EPS Growth | 36.23 | ★ 50.00 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $336,099,000.00 |
| Revenue This Year | N/A | $5.67 |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | ★ N/A | $82.00 |
| Revenue Growth | N/A | ★ 11.27 |
| 52 Week Low | $1.01 | $7.79 |
| 52 Week High | $16.14 | $24.94 |
Technical Indicators
Market Signals| Indicator | ERAS | DEA |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 37.35 |
| Support Level | $1.50 | $21.75 |
| Resistance Level | $16.14 | $22.40 |
| Average True Range (ATR) | 1.03 | 0.49 |
| MACD | -0.38 | -0.11 |
| Stochastic Oscillator | 20.16 | 23.41 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.